Home 2015



Caring for patients with solid organ transplants

Donald Brooks, age 57, comes to the emergency department after fracturing his right hip in a skiing accident. He is admitted to the orthopedic...

Study: Fecal microbiota transplant effective in immunocompromised patients

Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the...

MARS®: The new frontier in treating acute liver failure

A type of dialysis, MARS removes toxins and replaces lost liver functions.

FDA approves Liposorber Apheresis System for pediatric use

On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS)...

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after the procedure; and patient education.

Through the kindness of strangers

Our editor-in-chief shares her the impact of a tendon transplant on her life and discusses the importance of organ and tissue donation.

New policies for evaluating living kidney donors approved by OPTN/UNOS

The OPTN/UNOS Board of Directors has approved policies aimed at creating greater consistency in the medical and psychosocial evaluation and informed consent processes for...

Study: Kidney transplant patients prone to early readmission

According to a study in the American Journal of Transplantation, 31% of kidney transplant patients are readmitted to the hospital within 30 days of...

FDA approves DNA test to help manage CMV infection in organ transplant patients

On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the...

FDA approves Nulojix for prevention of acute rejection in kidney transplant patients

The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had a kidney...

Maximizing organ donation through aggressive donor management

Currently, more than 110,000 Americans are on the waiting list for a life-saving organ transplant. Each year, more than 5,000 people die while still...

More than half of liver transplant recipients develop metabolic syndrome

According to a study in January’s Liver Transplantation, more than half (52%) of liver transplant recipients develop metabolic syndrome. Read more at http://onlinelibrary.wiley.com/doi/10.1002/lt.22198/abstract.

Nurturing the tree of life

In the United States, more than 15,000 families a year make the difficult decision to donate their loved ones’ organs. One day in August...

Most Recent Content